Basic Information
One BioMed, a startup from A*STAR's Institute of Microelectronics, is developing in vitro diagnostic platforms to meet global health needs for decentralized point-of-care (POC) diagnostic testing. The company’s first flagship product is an affordable, simple, and integrated diagnostic device capable of rapidly detecting infectious diseases based on a unique silicon photonics technology platform.
One BioMed Pte Ltd
Singapore
less than 15 people
January 01, 2016
info@onebiomed.com

